SMA Community Update from Novartis Gene Therapies

We are pleased to share a community update on Novartis Gene Therapies’ Clinical Trial Program.

Do you like what you're reading?

Help make a difference in the lives of people affected by spinal muscular atrophy.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top